(Reuters) - A new drug to treat a breathing disorder that is the leading cause of death of premature babies cleared a regulatory hurdle, allowing Discovery Laboratories Inc to release it in the United States before the end of the year.

via Reuters: Health News Read More Here..
No comments:
Post a Comment